1
|
Soto-Retes L, Milagro J, Crespo-Lessmann A, Curto E, Medina ÉFM, Bailón R, Gil E, Laguna P, Plaza V. Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma. Ann Allergy Asthma Immunol 2024; 133:430-436. [PMID: 39074657 DOI: 10.1016/j.anai.2024.07.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 07/04/2024] [Accepted: 07/22/2024] [Indexed: 07/31/2024]
Abstract
BACKGROUND Patients with severe asthma often have uncontrolled disease and experience mood disorders, particularly anxiety and depression. The autonomic nervous system (ANS) plays an important role in asthma, mainly through the parasympathetic ANS system (PANS), which favors bronchoconstriction and mental health status. OBJECTIVE To evaluate the role of the activation of the PANS in uncontrolled asthma and related mood disorders. METHODS This was a proof-of-concept cross-sectional study that analyzed demographic and clinical variables reflecting asthma severity and control, lung function, inflammation (from induced sputum), evaluation of quality of life, and the risk for anxiety and depression according to validated questionnaires. The PANS analysis was conducted based on heart rate variability: SD of the difference between consecutive normal-to-normal (NN) intervals (SDNN), root mean square of the successive differences (RMSSD), percentage of consecutive NN intervals (pNN50), total power (TP), and respiratory-related power (Pr). RESULTS A total of 30 patients with asthma were grouped according to asthma control and the risk for anxiety and depression; 10 patients with uncontrolled asthma compared with the patients with controlled asthma showed significant differences (P < .05) in SDNN (26.5 [8.2] vs 42.7 [29.7]), RMSSD (14.1 [6.5] vs 24 [20]), pNN50 (0.6 [1.5] vs 6.2 [11.8]), TP (0.0005 [0.00046] vs 0.0014 [0.00085]), and Pr (0.0003 [0.00025] vs 0.0007 [0.00060]) respectively. A total of 13 patients at risk for anxiety and depression compared with the patients without showed reduced values (P < .05) for SDNN (26.5 [7.9] vs 45.6 [31.3]), pNN50 (0.75 [1.4] to 7.12 [12.6]), TP (0.0005 [0.00048] to 0.0012 [0.0008]), and Pr (0.0003 [0.00027] to 0.0008 [0.00062]). CONCLUSION Our results suggest that PANS activity is depressed in patients with uncontrolled asthma and common mood disorders such as depression and anxiety, and the evaluation of heart rate variability may be a useful means for follow-up of asthma control and related mood disorders.
Collapse
Affiliation(s)
- Lorena Soto-Retes
- Pneumology and Allergy Department, Hospital de la Santa Creu i Sant Pau and Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Institut de Investigació Biomédica Sant Pau, Barcelona, Spain.
| | - Javier Milagro
- Biomedical Signal Interpretation and Computational Simulation Group, Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain
| | - Astrid Crespo-Lessmann
- Pneumology and Allergy Department, Hospital de la Santa Creu i Sant Pau and Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Institut de Investigació Biomédica Sant Pau, Barcelona, Spain
| | - Elena Curto
- Pneumology Department, Salamanca University Hospital, Salamanca, Spain
| | - Éder F Mateus Medina
- Pneumology and Allergy Department, Hospital de la Santa Creu i Sant Pau and Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Institut de Investigació Biomédica Sant Pau, Barcelona, Spain
| | - Raquel Bailón
- Biomedical Signal Interpretation and Computational Simulation Group, Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain
| | - Eduardo Gil
- Biomedical Signal Interpretation and Computational Simulation Group, Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain
| | - Pablo Laguna
- Biomedical Signal Interpretation and Computational Simulation Group, Aragón Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain
| | - Vicente Plaza
- Pneumology and Allergy Department, Hospital de la Santa Creu i Sant Pau and Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Institut de Investigació Biomédica Sant Pau, Barcelona, Spain
| |
Collapse
|
2
|
Fantin A, Patruno V, Sartori G, Crisafulli E. Autonomic nervous system alterations in patients with mild-to-moderate asthma: do not forget airflow obstruction! A lesson from COPD. J Asthma 2022; 60:1054-1055. [PMID: 35972058 DOI: 10.1080/02770903.2022.2114085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
Affiliation(s)
- Alberto Fantin
- Department of Pulmonology, S. Maria della Misericordia University Hospital, Udine, Italy
| | - Vincenzo Patruno
- Department of Pulmonology, S. Maria della Misericordia University Hospital, Udine, Italy
| | - Giulia Sartori
- Department of Medicine, Respiratory Medicine Unit, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
| | - Ernesto Crisafulli
- Department of Medicine, Respiratory Medicine Unit, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
| |
Collapse
|